Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.
Novo Nordisk buckles down on lobbying efforts, inching toward CMS coverage of obesity treatments
Novo Nordisk has spent the summer building out its lobbying team on K Street as part of its efforts to get Medicare to cover obesity
August 12, 2023